Is LifeMD, Inc. a good investment? LifeMD, Inc. (LFMD) is currently trading at 3.73 USD. Market analysts have a consensus price target of 9.88 USD. This suggests a potential upside from current levels.
Earnings Schedule: LifeMD, Inc. is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 0.52.
No, it does not currently pay a dividend.
LifeMD, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of -0.44.
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 14, 2020 | 0.200000 |
Community Discussion